Showing results 707 to 726 of 3320
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2002 | Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: Implications for the prediction of disease severity | Whitfield, P.; Nelson, P.; Sharp, P.; Bindloss, C.; Dean, C.; Ravenscroft, E.; Fong, B.; Fietz, M.; Hopwood, J.; Meikle, P. |
| 2006 | Corrigendum: FRA16D common chromosomal fragile site oxido-reductase (FOR/WWOX) protects against the effects of ionizing radiation in Drosophila | O'Keefe, L.; Liu, Y.; Perkins, A.; Dayan, S.; Saint, R.; Richards, R. |
| 2004 | Cortical control of human jaw muscles: bilateral but not symmetrical | Nordstrom, M.; Pearce, S. |
| 2004 | Cortisol infusion decreases renin, but not PGHS-2, EP2, or Ep4 mRNA expression in the kidney of the fetal sheep at days 109-116 | Williams, S.; Olson, D.; Zaragoza, D.; Coulter, C.; Butler, T.; Ross, J.; McMillen, I. |
| 2008 | Cortisol inhibits neuroplasticity induction in human motor cortex | Sale, M.; Ridding, M.; Nordstrom, M. |
| 2012 | Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress | Kruiswijk, F.; Yuniati, L.; Magliozzi, R.; Low, T.; Lim, R.; Bolder, R.; Mohammed, S.; Proud, C.; Heck, A.; Pagano, M.; Guardavaccaro, D. |
| 2010 | Coupling of receptor conformation and ligand orientation determine graded activity | Bruning, J.; Parent, A.; Gil, G.; Zhao, M.; Nowak, J.; Pace, M.; Smith, C.; Afonine, P.; Adams, P.; Katzenellenbogen, J.; Nettles, K. |
| 2005 | Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection | Le Mire, M.; Miller, D.; Foster, W.; Burrell, C.; Jilbert, A. |
| 2021 | CPAP increases physical activity in obstructive sleep apnea with cardiovascular disease | Stevens, D.; Loffler, K.A.; Buman, M.P.; Dunstan, D.W.; Luo, Y.; Lorenzi-Filho, G.; Barbe, F.E.; Anderson, C.S.; McEvoy, R.D.; The Save Investigators, |
| 2008 | CreA-mediated repression in Aspergillus nidulans does not require transcriptional auto-regulation, regulated intracellular localisation or degradation of CreA | Roy, P.; Lockington, R.; Kelly, J. |
| 2022 | Critical assessment of computational tools for prokaryotic and eukaryotic promoter prediction | Zhang, M.; Jia, C.; Li, F.; Li, C.; Zhu, Y.; Akutsu, T.; Webb, G.I.; Zou, Q.; Coin, L.J.M.; Song, J. |
| 2010 | Critical role of FLRT1 phosphorylation in the interdependent regulation of FLRT1 function and FGF receptor signalling | Wheldon, L.; Haines, B.; Rajappa, R.; Mason, I.; Rigby, P.; Heath, J.; Neylon, C. |
| 2013 | Crosstalk between mTOR complexes | Xie, J.; Proud, C.G. |
| 2023 | "Crowd-control" by RNA: a pervasive theme in biology | Bracken, C.P. |
| 2007 | Cro’s role in the CI–Cro bistable switch is critical for λ’s transition from lysogeny to lytic development | Schubert, R.; Dodd, I.; Egan, J.; Shearwin, K. |
| 2001 | CRTR-1, a developmentally regulated transcriptional repressor related to the CP2 family of transcription factors | Rodda, Stephen James; Sharma, Shiwani; Scherer, Michaela Anne; Chapman, Gavin; Rathjen, Peter David |
| 2012 | Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole | Espinel-Ingroff, A.; Aller, A.; Canton, E.; Castanon-Olivares, L.; Chowdhary, A.; Cordoba, S.; Cuenca-Estrella, M.; Fothergill, A.; Fuller, J.; Govender, N.; Hagen, F.; Illnait-Zaragozi, M.; Johnson, E.; Kidd, S.; Lass-Florl, C.; Lockhart, S.; Martins, M.; Meis, J.; Melhem, M.; Ostrosky-Zeichner, L.; et al. |
| 2016 | Curcumin inhibits activation of TRPM2 channels in rat hepatocytes | Kheradpezhouh, E.; Barritt, G.; Rychkov, G. |
| 2003 | Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery | Gosbell, I.; Toumasatos, V.; Yong, J.; Kuo, R.; Ellis, D.; Perrie, R. |
| 2014 | Current and future targets of antiviral therapy in the hepatitis C virus life cycle | Eyre, N.; Helbig, K.; Beard, M. |